Medicare Enrolled

Dr. Jack Waxman, M.D.

Rheumatology · Santa Rosa, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
4015 QUARTZ DR, Santa Rosa, CA 95405
7074817215
In practice since 2005 (20 years)
NPI: 1104824994 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Waxman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Waxman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Waxman

Dr. Jack Waxman is a rheumatology specialist in Santa Rosa, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Waxman performed 407 Medicare services across 97 unique beneficiaries.

Between the years covered by Open Payments, Dr. Waxman received a total of $100,690 from 46 pharmaceutical and/or device companies across 1276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Waxman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 407 Medicare services $100,690 industry payments

Medicare Practice Summary

Medicare Utilization ↗
407
Medicare services
Bottom 34% in CA for rheumatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
97
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~20 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
260 $60 $150
Nursing facility visit, moderate complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes.
114 $86 $199
Initial nursing facility care, high complexity
An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes.
33 $141 $180
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$100,690
Total received (2018-2024)
Avg $14,384/year across 7 years
Top 8% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
1,276
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$81,556 (81.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,231 (18.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$903 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$998
2023
$648
2022
$605
2021
$6,374
2020
$14,878
2019
$50,774
2018
$26,413

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$353
UCB, Inc.
$186
Janssen Scientific Affairs, LLC
$169
ABBVIE INC.
$115
Aurinia Pharma U.S., Inc.
$79
Radius Health, Inc.
$52
PFIZER INC.
$45
Top 3 companies account for 71.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$41,643
Novartis Pharmaceuticals Corporation
$24,999
PFIZER INC.
$12,474
Horizon Pharma plc
$3,437
Horizon Therapeutics plc
$3,144
AbbVie, Inc.
$1,782
AbbVie Inc.
$1,779
Janssen Biotech, Inc.
$1,565
Radius Health, Inc.
$1,132
GlaxoSmithKline, LLC.
$1,086
Janssen Scientific Affairs, LLC
$1,009
Lilly USA, LLC
$785
E.R. Squibb & Sons, L.L.C.
$660
GENZYME CORPORATION
$645
UCB, Inc.
$599
Celgene Corporation
$586
Mallinckrodt Hospital Products Inc.
$450
Alexion Pharmaceuticals, Inc.
$381
Biohaven Pharmaceuticals, Inc.
$327
Boehringer Ingelheim Pharmaceuticals, Inc.
$302
Genentech USA, Inc.
$249
Takeda Pharmaceuticals U.S.A., Inc.
$222
Mallinckrodt Enterprises LLC
$221
Aurinia Pharma U.S., Inc.
$176
Mallinckrodt LLC
$154
ABBVIE INC.
$115
AstraZeneca Pharmaceuticals LP
$102
MEDAC PHARMA, INC.
$82
Hikma Pharmaceuticals USA
$76
West-Ward Pharmaceuticals
$62
Gilead Sciences, Inc.
$51
Biogen, Inc.
$45
Allergan, Inc.
$41
Genentech, Inc.
$39
MEDEXUS PHARMA, INC.
$38
Allergan Inc.
$36
Assertio Therapeutics, Inc.
$33
Daiichi Sankyo Inc.
$30
Actelion Pharmaceuticals US, Inc.
$22
Merck Sharp & Dohme Corporation
$18
Janssen Pharmaceuticals, Inc
$18
Melinta Therapeutics, Inc.
$17
SANOFI-AVENTIS U.S. LLC
$17
ASSERTIO THERAPEUTICS, Inc.
$16
Ultragenyx Pharmaceutical Inc.
$14
Zyla Life Sciences
$14
Top 3 companies account for 78.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ANORO · AVSOLA · Actemra · BENLYSTA · BOSENTAN TABLETS · BREO · Baxdela · Bimzelx · CABENUVA · COSENTYX · Cabenuva · Cimzia · Crysvita · EVENITY · Enbrel · FORTEO · Gralise · HUMIRA · Humira · INFLECTRA · INJECTAFER · JANUVIA · KEVZARA · KRYSTEXXA · LINZESS · LUPKYNIS · LYRICA · Mitigare · NURTEC ODT · OFEV · ORENCIA · Otezla · PENNSAID · Prolia · RAYOS · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STIOLTO RESPIMAT · Strensiq · TALTZ · TAVNEOS · TRELEGY ELLIPTA · TREMFYA · TRULICITY · Trintellix · Tymlos · UBRELVY · UPTRAVI · Uloric · VIIBRYD · XELJANZ · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for rheumatology in CA.

Looking for a rheumatology specialist in Santa Rosa?
Compare rheumatologists in the Santa Rosa area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
6
Per 100K population
1.2
County median income
$102,840
Nearest hospital
PROVIDENCE SANTA ROSA MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Waxman is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 8% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Waxman experienced with nursing facility visit, low complexity?
Based on Medicare claims data, Dr. Waxman performed 260 nursing facility visit, low complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Waxman receive payments from pharmaceutical companies?
Yes. Dr. Waxman received a total of $100,690 from 46 companies across 1,276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Waxman's costs compare to other rheumatologists in Santa Rosa?
Dr. Waxman's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Waxman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →